In other countries
The same active substances on other registers, the same brand first.
- Emend InjetávelBrazil · Merck Sharp & Dohme Farmaceutica Ltda.Same brand
- EmendBrazil · Organon Farmacêutica Ltda.Same brand
- Emend InjetávelBrazil · Organon Farmacêutica Ltda.Same brand
- Emend 125 MG Capsulas Duras/Emend 80 MG Capsulas DurasSpain · 225 mg · cápsula dura · Merck Sharp & Dohme B.V.Same brand
- Emend 80 MG Capsulas DurasSpain · 80 mg · cápsula dura · Merck Sharp & Dohme B.V.Same brand
- Emend 125 MG Polvo Para Suspension OralSpain · 125 mg · polvo para suspensión oral · Merck Sharp & Dohme B.V.Same brand
- EmendEuropean Union · Merck Sharp & Dohme B.V.Same brand
- EmendCroatiaSame brand
- EmendItaly · Capsula rigida · Merck Sharp & Dohme B.V.Same brand
- Emend 125 mg capsules, capsulesNetherlands · Capsule, hard · Merck Sharp & Dohme B.V.Same brand
- Emend 125 mg en 80 mg capsules, capsulesNetherlands · Capsule, hard · Merck Sharp & Dohme B.V.Same brand
- Emend 80 mg capsules, capsulesNetherlands · Capsule, hard · Merck Sharp & Dohme B.V.Same brand
- Emend Tri-PackNew Zealand · Cap 2 x 80 mg and 1 x 125 mgSame brand
- EMEND 125mg + 80mgRomania · 125mg+80mg · caps. · Merck Sharp & Dohme B.V.Same brand
- EMEND 125mg + 80mgRomania · 125mg+80mg · caps. · Merck Sharp & Dohme LTDSame brand
- Emend®Serbia · 125mg;80mg · kapsula, tvrda · Merck Sharp & Dohme D.O.O.Same brand
- EMEND CAPSULE 80 mgSingapore · 80 mg · capsule · MSD Pharma (Singapore) Pte. LTD.Same brand
- Emend Tri-Pack CapsuleSingapore · 125 mg + 80 mg · capsule · MSD Pharma (Singapore) Pte. LTD.Same brand
- Emend® I.V. Powder for Solution for Infusion 150mgSingapore · 150.0 mg · injection, powder, lyophilized, for solution · MSD Pharma (Singapore) Pte. LTD.Same brand
- EmendUnited States · 125MG, 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 80MG · capsule · MSDSame brand
- EmendUnited States · 125MG/KIT · for suspension · MSD Merck CoSame brand
- EmendUnited States · 115MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 150MG BASE/VIAL · powder · Merck and Co INCSame brand
- Aprepitant Alpha-Medical 125 mg + 80 mg tvrde kapsuleCroatia · kapsula, tvrda · Alpha-Medical d.o.o., Dragutina Golika 36, Zagreb, HrvatskaSame form
- Aprepitant Teva 125 mg + 80 mg tvrde kapsuleCroatia · kapsula, tvrda · Teva B.V., Swensweg 5, Haarlem, NizozemskaSame form
- Aprepitant AccordItaly · Capsula rigida · Accord Healthcare, S.L.U.Same form
- Aprepitant TevaItaly · Capsula rigida · Teva B.V.Same form
- Nauzex®Serbia · 125mg;80mg · kapsula, tvrda · Actavis D.O.O. BeogradSame form
- Nauzex®Serbia · 125mg;80mg · kapsula, tvrda · Actavis D.O.O. BeogradSame form
- Enevom 125 MG CapsuleSaudi Arabia · Rontis Hellas S.A., Medical and Pharmaceutical ProductsSame form
- Enevom 80 MG CapsuleSaudi Arabia · Rontis Hellas S.A., Medical and Pharmaceutical ProductsSame form
- IvemendEuropean Union · Merck Sharp & Dohme B.V.Same substance
- EnvonaSaudi Arabia · MSN Laboratories Private LimitedSame substance
- Apreto Capsules 125mgTaiwan · 膠囊劑 · 萬達藥業有限公司Same substance
- Innomend Capsules 125mgTaiwan · 膠囊劑 · 美時化學製藥股份有限公司Same substance
- Innomend Capsules 80mgTaiwan · 膠囊劑 · 美時化學製藥股份有限公司Same substance
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Health Canada, Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Aprepitant
- Strength
- 125 MG + 80 MG
- Dosage form
- Capsule, Kit
- Route
- Oral
- Register
- Canada (Health Canada)
- Status
- Marketed
- Authorised
- 24 Sept 2007
- Registration
- DIN 02298813
- Marketing authorisation holder
- Merck Canada INC
- ATC code
- A04AD12
- Supply
- PRESCRIPTION